Brief: Shilpa Medicare Ltd Says Shilpa Biologicals And Steincares To Commercialize Biosimilar In Latin America
24/02/2026 05:07
Feb 24 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA MEDICARE LTD - BIOLOGICALS AND STEINCARES TO COMMERCIALIZE BIOSIMILAR IN LATIN AMERICA SHILPA MEDICARE LTD - BIOLOGICALS TO DEVELOP AND MANUFACTURE BIOSIMILAR IN INDIA Source text: ID:nBSE1MMxp4 Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026